A pharmaceutical composition for topical administration comprising 2 3 dimethyl 6 (N N dimethylaminoethyl) 6H indolo (2 3 b)quinoxaline (B 220) or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier. The composition is useful for the treatment of herpes virus infections of the skin or mucous membranes in a mammal subject.